USFDA inspection of Shilpa Medicare Unit VI at Bengaluru
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
Aims to achieve CDMO sales of US$ 400 million by 2028
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Subscribe To Our Newsletter & Stay Updated